author-photo

Barry L. Gause

National Institutes of Health

32

Papers

1892

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Idiotype vaccine therapy of follicular lymphoma in first remission: Association of t(14;18) and disease free survival in a phase II cohort

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Synchronous indolent primary gastrointestinal lymphomas managed successfully with conservative measures.

2013 American Journal of Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response

2012 Haematologica
Show All
- Source
- Cite
- Save
Citations (92)
Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (87)
A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma

2007 Blood
Show All
- Source
- Cite
- Save
Citations (32)
Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: Results of a phase II study

2000 Cancer Journal
Show All
- Source
- Cite
- Save
Citations (34)
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.

2000 The cancer journal from Scientific American
Show All
- Source
- Cite
- Save
Citations (12)
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1999 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (566)
Treatment with tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients

1999 Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (22)
Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin

1999 Blood
Show All
- Source
- Cite
- Save
Citations (18)